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Lymphocyte products released during the human mixed reaction were studied for their ability
tostimulate human monocytes to produce endogenous pyrogen and lymphocyteactivating factor.
These two biological activities are considered properties ofthe same molecule, called interleukin-
1 (IL-1). In these experiments, physical characteristics such as molecular weight, isoelectric
point, and binding to concanavalin A (Con A) sepharose were studied under conditions which
excluded bacterial endotoxins. Gel filtration revealed molecular weights ofapproximately 60 and
25 kD with IL-I-inducing activity. Isoelectric points ranged from 5.9 to 6.3. The IL-I-inducing
properties ofmixed leukocyte reaction supernates did not bind to Con A sepharose. Recombinant
human gamma interferon did not induce IL-I production under various conditions but rather
augmented IL-1 induced by endotoxin. In contrast, the mixed leukocyte reaction results in
production of lymphokines which directly stimulate IL-I production in the absence of endotox-
ins.
INTRODUCTION
Host responses to various microbial challenges are characterized by a constellation
of metabolic, endocrinologic, immunologic, and neurologic changes. Of the many
responses which can bemeasured following theonsetofmicrobial infection, feverranks
as one ofthe most dramatic. Despite the lack oftemperature-measuring devices, fever
had been described with remarkable detail for many centuries [1]. The mechanism by
which microbial agents produce fever is now well established [2,3]. In brief, phagocytic
mononuclear cells are stimulated by the microbe or its products and synthesize a
polypeptide called endogenous pyrogen (EP). EP enters the circulation and causes
fever by stimulating the synthesis of cyclo-oxygenase products of arachidonic acid
metabolism in the hypothalamic area. The most likely product is prostaglandin E2
(PGE2) but other PGs may be involved. Although the precise location for EP's action
in the hypothalamus remains unclear, the molecule also circulates in the peripheral
circulation where it affects other tissues.
Theextra-CNS activitiesofEPhave been recentlystudied. Theseinclude the ability
of EP to activate PGE2 synthesis in skeletal muscle tissue, which contributes to the
muscle wasting offebrile diseases, and in chondrocytes and synovial fibroblasts, which
contribute to joint pain and enzymatic tissue destruction. In addition, EP augments
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lymphocyte responses to antigens and mitogens. This latter property of EP is often
called lymphocyte activating factors (LAF). In several laboratories, LAFand EP have
not been separated. Homogeneous preparations have both activities and hence it seems
likely that these are properties ofthe same molecule. The term interleukin-1 (IL-1) is
used to describe this molecule with EP, LAF, and other inflammatory properties [4].
In this report, studies are presented on the chemical nature oflymphocyte products
produced during the mixed leukocyte reaction (MLR) which stimulate human
monocytes to synthesize IL-1 [5]. These studies examine endogenously produced
IL-I-stimulating factors rather than thoseofmicrobial origin. The production ofthese
IL-i-inducing factors in the MLR is due to the antigenic stimulus provided by
alloantigens. Thus, theclinicalrelevanceoftheseexperiments canbedirectlyrelated to
fever and other host responses associated with rejection of foreign tissue or graft-
versus-host reactions. In a broader sense, these experiments are also related to
mechanisms of fever in several immunologically mediated diseases in which the
primary response is the stimulation of specifically sensitized T-cells. This model of
using a product derived from sensitized T-cells to stimulate IL-I production was first
described by Atkins and co-workers in 1972 [6] and further expanded in subsequent
reports [7-9]. In addition, concanavalin A (Con A) has been used to stimulate the
production ofEP-inducing factors from human lymphocytes [10].
The physical nature of these factors elaborated by T-cells has not been character-
ized. Ofparticular importance to these studies is the exquisite sensitivity ofmonocytes
to endotoxin. Picogram/ml amounts of endotoxins stimulate IL-I production in vitro
[II]. Hence in characterizing the physical properties of the MLR supernate for its
ability to induce IL-I production, extraordinary care must be used to avoid spurious
stimulation by endotoxins. Using specific procedures designed to eliminate the
introduction of endotoxins and incorporating polymyxin B, which inhibits the IL-
I-inducing property ofendotoxin into the monocyte culture media [12], we report here
the direct stimulation of human monocyte IL-I production by factors present in the
MLR supernate.
MATERIALS AND METHODS
Materials
All glassware, water, buffers, and gel-filtration media were pyrogen-free. Sand-
filtered, reverse osmosis, and ion-exchange water was filtered through a polysulfon
Nucleopore filter (exclusion of 300 Daltons) at 25 pounds per square inch (HydroSer-
vices, Durham, NC). The endotoxin content ofthis water was below that detectable in
the limulus assay (see the following paragraph). Water used in these experiments for
column buffers was autoclaved for 90 minutes. Dialysis tubing (Spectopor, Los
Angeles, CA) was rinsed in pyrogen-free water, autoclaved for 30 minutes, and then
rinsed again with sterile water. Alpha methyl D-mannoside (grade III) was purchased
fromSigma (St. Louis, MO). Human recombinant gamma interferon (IFN) was agift
from Genentech, Inc., South San Francisco, CA. Concanavalin A (Con A) sepharose
was purchased from Sigma; phytohemagglutinin (PHA) wasobtained from Burroughs
Wellcome (Research Triangle, NC).
MLR Supernates
Human peripheral blood mononuclear cells were isolated from two unrelated
donors, suspended in minimal essential medium (MEM; Microbiological Associates,
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Walkerville, MD), mixed, and incubated in upright polypropylene tubes as described
previously [5]. Lots ofMEM used in all cultures werescreened for endotoxin using the
limulus amebocyte lysate (LAL) test from Associates ofCapeCod (Woods Hole, MA)
with a sensitivity of 50 pg/ml. The lot of MEM used in these studies contained less
than 50 pg/ml and did not stimulate IL-I production from human mononuclear cells.
MLR supernatant media were cultured for bacterial contamination, centrifuged,
pooled, and concentrated tenfold in autoclaved dialysis bags by evaporation. The pools
were aliquoted and kept frozen at -700C until used.
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FIG. 2. Gel filtration of concentrated MLR supernates. LAF activity is shown in solid bars and EP
activity is shown in open bars. Each fraction pool was assayed directly for intrinsic LAF (at 1:100 dilution)
or EP by injecting 5.0ml/rabbit. The results represent the mean fever peak ± SEM in three rabbits.
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FIG. 3. Gel filtration of concentrated MLR supernates which induce EP. Gel filtration took place over
G-50 (165 x 5.5 cm) in 0.15 MNaCl at 40C. Each fraction pool wasdialyzed against MEM,diluted 1:8, and
assayed for EP (shown in solid bars). The open bars represent the same fractions incubated with human
monocytes for 48 hours and the supernatant medium injected into rabbits.
Chromatographic Methods
Two types of chromatographic separations were employed: gel filtration and
isoelectric focusing. All gel-filtration media and buffers were autoclaved and were
non-reactive in the LAL. All columns were sterilized by either a 10 percent formalde-
hyde rinse or 15 minutes of autoclaving. Test tubes were either pyrogen-free
polypropylene or siliconized and baked glass (1800C for four hours). Eluted fractions
were not filtered but rather cultured to ascertain sterility. In addition, LAL assays
were carried out on fractions to ascertain the endotoxin concentration.
All focusing materials were sterilized and washed with LAL-negative water. The
isoelectric focusing gel (flatbed) was Sephadex G-75 superfine using an LKB
apparatus. MLR supernatant pools were dialyzed in autoclaved standard dialysis bags
(molecular weight cut-off = 8-10 kD) against 2,000 volumes of 1 mM NaCl and then
mixed with LKB ampholines. The slurry was poured on toa glassplate, dried to a paste
using a fan, and focused at 40C with 8 watts constant power. After 24 hours, the paste
was divided into fractions, each fraction was suspended in water (final ampholine
concentration of0.5 percent w/v), and pH was determined at 200C. Thefractions were
then further diluted in MEM and the supernates cultured for bacteria.
Induction ofIL-I
Crude or chromatographic fractions derived from MLR supernatants were assayed
employing the mononuclear cells of an unrelated donor as described previously [5].
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FIG. 4. Gel filtration of concentrated MLR supernates which induce LAF. Gel filtration took place over
G-50 (80 x 1.5 cm) in MEM at 4°C. Each fraction was diluted 1:100 and assayed for intrinsic LAF activity
(shown in solid bars). The open bars represent the same fractions diluted 1:10 and incubated with human
monocytes for 48 hours. The supernatant medium was diluted 1:10 and assayed for LAF on the same set of
thymocytes.
Mononuclear cells were suspended in MEM at a concentration of 5 x 106/ml
containing 2 percent heat-inactivated human AB serum from a single donor. 1.0 ml of
cells was aliquoted into each 2 cm diameter well (Costar, Hamden, CT) and the plate
was gently rocked at 37°C for two hours. The non-adherent cells were then washed off
with two rinses of warm MEM. The fractions to be tested were diluted in MEM
containing 0.1 percent human AB serum and 12.5 ,ug/ml polymyxin B [12]. Each well
was filled with 1.0 ml ofdiluted sample. After 48 hours, the supernatant medium from
each well was centrifuged (1,500 g) and assayed for IL-i1 activity. For induction of EP
activity, larger amounts were required. To accomplish this, the same protocol was used
except the 5 ml of cells were seeded on to 25 cm2 flasks and 5.0 ml of diluted MLR
fraction was added.
Assayfor IL-I Activity
Following stimulation, the supernatant was diluted and incubated with murine
thymocytes as previously described [13] in the presence of 12.5 ,ug/ml ofpolymyxin B.
Since some fractions eluting from either gel filtration or isoelectric focusing contained
intrinsic LAF activity, each fraction was diluted and assayed for LAF activity directly,
using the same thymocytes being employed to assay the LAF activity induced by these
same fractions. Thus, the data are presented as LAF activity "present in the MLR
supernate" as well as that "induced from monocytes by MLR supernate."
Fever production was assayed by the rabbit pyrogen test as described previously
[14]. Each fraction or supernate was assayed in three rabbits. The amount ofsupernate
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FIG. 5. Gel filtration ofconcentrated MLR supernates which induce LAF. Gel filtration took place over
G-150 (80 x 1.5cm) in MEM at40C. Each fraction wasdiluted 1:100andassayed forintrinsic LAFactivity
(shown in solid circles). The open circles represent the same fractions diluted 1:10 and incubated with
human monocytes for 48 hours. Thesupernatant medium wasdiluted 1:10 and assayed for LAF on the same
set ofthymocytes.
injected intravenously was equivalent to 1.2 x 106 monocytes/kg. Data are expressed
at mean of peak increase over baseline line rectal temperature (± SEM). All fevers
were monophasic, rapid in onset, and reached a peak elevation between 48-60 minutes
following injection.
RESULTS
Generation Time ofEPDuring the MLR
A pool of supernates from several two-way MLRs derived from the mononuclear
cells of different donors was prepared as described in Methods. This MLR supernate
pool was diluted 1:10 and mixed with the mononuclear cells of a single donor. The
mixture was then divided into seven 5 ml aliquots in 25 cm2 flasks. Mononuclear cells
from the same donor were also mixed with heat-killed S. albus and similarly divided
intoflasks. All flasks wereincubated at 37°C; flasks were removed atvarious times, the
cultures centrifuged, and supernates were stored at 40C until tested for pyrogenicity.
As shown in Fig. 1, EP was detected in the supernate ofmononuclear cells stimulated
with S. albus after six to nine hours, whereas the same amount ofEP was not detected
in MLR-stimulated cultures for 24-48 hours. Similar results have been reported for
guinea pig monocyte EP induced by supernates derived from sensitized lymphocytes
incubated with specific antigen [15].AN IL-1 INDUCER DERIVED FROM HUMAN MLRs
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FIG. 6. Gel filtration of concentrated MLR supernates which induce LAF and EP. Gel filtration took
place over G-150 (145 x 2.0 cm) in MEM at 40C. Every five fractions were pooled, diluted 1:100, and
assayed for intrinsic LAFactivity (shown insolidbars). The open bars represent the same fractions diluted
1:10 and incubated with human monocytes for 48 hours. The supernatant medium was diluted 1:10 and
assayed for LAF on the same set of thymocytes. Fraction pools B and F-H were also incubated with
monocytes, and the supernates were injected into rabbits. The inset depicts the mean peak fever produced
from these fractions.
Molecular Weight Determinations ofEPand LAFPresent in MLR Supernates
Initial experiments to characterize the IL-i-inducing property of MLR supernates
involved concentration ofa large (500 ml) pool ofsupernates prior tochromatographic
separations. The concentrate contained EP and LAF activity. In order to identify the
molecular weight speciesofEPand LAFactivity in theconcentrated pool, the pool was
chromatographed over Sephadex G-50 and every five fractions were combined and
assayed for EPand LAFactivity. As shown in Fig. 2, EPand LAFco-elute in the same
fraction pools at molecular weights ofapproximately 38 and 16 kD. Similar molecular
weight determinations have been reported for human EP and LAF when the
monocytes are stimulated with either heat-killed S. albus or bacterial endotoxin [4].
Thus, the MLR supernate pool contains EP and LAF with molecular weights
indistinguishable from those observed using microbial inducers. Using these data, all
subsequent experiments were carried out measuring both the intrinsic EP and LAF
activity ofeach fraction andthe EP and LAF induced by such fractions.
Molecular Weight Determination ofIL-I-InducingSubstance(s)
in MLR Supernates
The concentrated pool of MLR supernates was chromatographed over G-50 and
every ten fractions were combined. Each pool was injected directly into rabbits to
determine the intrinsic EP activity. Each pool was also incubated with the monocytes
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FIG. 7. Isoelectricfocusing ofMLRsupernates. Each fraction wasdialyzedagainstMEM, diluted(1:10),
and assayed for intrinsic LAF activity (shown in solid bars). These fractions were also incubated with
human monocytes at a dilution of 1:5 and the supernates assayed for LAF (open bars) at a 1:10 dilution.
from a single donor for 48 hours. The supernates from these latter incubations were
injected into the same rabbits. As shown in Fig. 3, two pools contained EP-inducing
activity. The approximate molecular weights of these pools are >50 and 20-30 kD.
There was also a small amount of EP-inducing activity at 8-10 kD. Further
experiments were designed using smaller columns and determination ofLAF-inducing
activity in the MLR supernate.
In the next experiment, the MLR pool was chromatographed over a small G-50
column; each fraction was diluted and assayed directly for intrinsic LAF activity as
well as incubated with human mononuclear cells for LAF-inducing activity. As shown
in Fig. 4, the same elution profile was obtained using LAF-inducing activity. The
dilution of each fraction was below the detection of intrinsic LAF, whereas LAF-
inducing activity was found in fractions >50, 20-30, and 8-10 kD, similar to the
results shown in Fig. 3.
In further experiments, the MLR supernate pool was chromatographed over G-150
inorder todetermine the sizeofthe IL-I-inducing peakeluting at >50kD. Once again,
each fraction was diluted and assayed for intrinsic LAF activity and also incubated
with monocytes for LAF-inducing activity. As shown in Fig. 5, LAF-inducing activity
was detected in fractions eluting at approximately 60 kD and 20-30 kD.
In order to test for EP-inducing activity in the 60 kD fractions, a large G-150
column was used. The eluted fractions werecombined and evaluated for LAF-inducing
activity. As shown in Fig. 6, a similar elution pattern wasobserved. Fraction pools were
also incubated with monocytes for EP-inducing activity, using activepools F, G, and H
as well as inactive pool B. EP-inducing activity was present in those pools which had
induced LAF (inset to Fig. 6).
Isoelectric Focusing ofMLR Supernates
Two isoelectric focusing experiments were done: one performed using a pool of
unconcentrated MLR supernates and another using a pool of MLR from several
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FIG. 8. Isoelectric focusing ofconcentrated MLR supernates. Each fraction was dialyzed, diluted (1:10O),
and assayed for intrinsic LAF activity (shown in solid bars). These fractions were also incubated with
human monocytes at 1:10 and the supernates assayed for LAF (open bars) at a 1:10 dilution.
donors which was concentrated prior to being tested. In each experiment, the focused
material was assayed for intrinsic LAF activity and was incubated with monocytes for
the elaboration ofLAF and EP.
The results of the unconcentrated MLR pool are shown in Fig. 7. There is a single
peak of LAF-inducing activity in fractions 13-15 with a pI 6-6.3. In the second
experiment using the concentrated MLR pool, fractions 15-17 induced the most LAF
activity and had a pl of 5.9-6.2 (see Fig. 8). There was also another peak of
LAF-inducing activity with a pl of 7.5. Fractions 15-17 were pooled and incubated
with human monocytes from a single donor in order to stimulate EP production.
Control fractions were also obtained (fractions 12-14 and 26-28). After 48 hours of
incubation, these supernates were injected intorabbits. Control fractions 13 and 14 did
not stimulate EP (T = 0.22 ± 0.060C). However, fractions 15-17 induced typical EP
fevers (T = 0.56 ± 0.080C).
IL-I-Inducing Activity ofMLR Supernatants Eluted From Con A Sepharose
Concentrated MLR supernatants were dialyzed against phosphate-buffered saline
(pH 7.4) and applied to a Con A sepharose column. The column was washed with one
volume of buffer and these were combined for assay on monocytes. The column was
then washed with two column volumes of 0.5 M alpha methyl D-mannoside. These
were pooled, diluted, and assayed for IL-1-inducing activity. The results are shown in
Table 1. As depicted, the IL-I-inducing activity does not bind to Con A sepharose but
rather is recovered in thenon-binding material. Washing the column with 0.5 M alpha
methyl D-mannoside did not result in the elution of an IL-i-inducing activity. These
experiments were repeated with similar results. During the repeat experiment, the
column was washed with 20 percent ethylene glycol following the alpha methyl
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TABLE 1
IL-1-Inducing Activity of MLR Supernatants
Materials Tested T "Ca cpMb
Experiment I
MLR (1:8) + MO 0.80 ± 0.1
MLR (1:80) + MO 6,135c
MLR (I:800) + MO 2,122
Non-binding (1:8) + MO 0.80 ± 0.02
Non-binding (1:10) + MO 6,886
Non-binding (1:100) + MO 4,965
AMM elution (1:8) + MO" 0.05 ± 0.03
AMM elution (1:10) + MO 2,511
AMM elution (1:100) + MO 2,201
Experiment 2
MLR (1:80) + MO 7,643
Non-binding (1:80) + MO 5,121
AMM elution (1:10) + MO 1,429
20% ethylene glycol' (1:10) + MO 5,968
Peak fever in three rabbits (± SEM)
bCPM subtracted from CPM ofthymocytes incubated without PHA
'The PHA response - 2,372 after subtraction ofthymocytes CPM without PHA
"Alpha methyl mannoside 0.5 M; controls containing 0.05 and 0.005 M AMM with unfractionated MLR
supernates were unaffected by the saccharide.
eDialyzed against MEM prior to assay on MO
D-mannoside elution. The 20 percent ethylene glycol wash contained significant
LAF-inducing activity, as shown in Table 1.
Effect ofRecombinant Human Gamma lFNon IL-I Production
Of the many lymphokines which are produced during a MLR, gamma IFN has
recently received attention as an important modulator of monocyte/macrophage
function [16-20]. Therefore, experiments were designed to test the ability ofhomoge-
neous human gamma IFN on monocyte IL-I production. Despite several trials using
concentrations ofgamma IFN from 10-' to IO0 units/ml, mononuclear cells from four
different donors did not produce IL-1. Cell lysates as well as cell supernatant media
contained no LAFactivity after 24 or 48 hours ofincubation. Indomethacin (1 ,ug/ml)
was added to cultures to block any suppressive effects of PGE2 but there was no
evidence that gamma IFN was inducing IL-1. These supernatants similarly did not
contain EP activity when injected into rabbits.
However, when small amounts of endotoxin were deliberately added to the culture
medium in the presence ofvarious amounts ofgamma IFN, the 24 supernatant media
contained increased LAF activity. The results are shown in Figs. 9A and 9B. In these
studies, polymyxin B was not added to the mononuclear cell cultures. As shown, the
amount of LAF produced was small and we could not demonstrate significant
increased EPactivity in these supernatants. Thus, weconclude from theseexperiments
that gamma IFN induces IL-I production by augmenting the stimulatory effects of
endotoxin. In fact, this finding may explain the findings of other investigators
employing gamma IFN in their experiments [21] since many tissue culture media
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contain between 0.5 and 5 ng/ml endotoxin, as determined by the LALassay (data not
shown).
DISCUSSION
These studies were undertaken to define the chemical characteristics oflymphocyte
products in the MLR which induce IL-1. There are many substances produced as a
result of the allogeneic stimulation in the MLR; some are clearly candidates for IL-I
inducers by nature of their ability to activate monocytes and macrophages. These
include migratory inhibitory factor (MIF), colony-stimulating factor (CSF), and
macrophage-activating factor (MAF). Recently, there has been considerable evidence
that some, although not all, MAF activity is due to gamma IFN [17,20]. The
availability of homogeneous preparations of human recombinant gamma IFN has
facilitated the testing of this substance as an inducer of IL-1 production. We were
unable, however, to demonstrate IL-1 production from human mononuclear cells
incubated with various concentrations ofgamma IFN in theabsenceofendotoxins. On
the contrary, gamma IFN augments endotoxin-induced IL-1 production and/or
release. This finding is consistent with several reports on the ability ofgamma IFN to
increase macrophageexpression ofmajor histocompatibility complex antigens [18,19]
and Fc receptor [16]. Others have also reported that alpha (leukocyte) IFN does not
stimulate IL-I production but ratheraugments IL-I production induced byendotoxins
[22]. Finally, we have shown that EP activity is augmented by small amounts of
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endotoxin which contaminate human recombinant alpha IFN [14]. We speculate that
some of the gamma IFN-mediated effects which have been reported, including
increased IL-1 production [21], may, in fact, be partially due to an augmentation
phenomenon ofendotoxins present in commercially available tissue culture media and
fetal calfserum.
The IL-I-inducing substance(s) reported in these studies is clearly not due to
endotoxins. Incorporating polymyxin B in the IL-I-inducing culture inhibits endotox-
in's ability to stimulate monocytes [12]. Furthermore, we have isolated IL-I-inducing
activity at molecular weights of 60 and 30 kD, whereas endotoxins elute from
gel-filtration chromatography at molecular weights >200 kD. In addition, the
isoelectric point of the IL-I-inducing activity is 5.9-6.3, whereas endotoxins bind
avidly to ion-exchange media at pH above neutrality, indicating a strongly negatively
charged molecule. Finally, the heat lability of the IL-I-inducing activity would
preclude endotoxin [5]. We conclude that the IL-1-inducing activity of MLR
supernates is ofendogenous origin (lymphocytes) and that the physical characteristics
reported here are due to the direct stimulation of IL-I production rather than an
augmentation ofendotoxin's effects.
There are several possibilities that the IL-I-inducing substance(s) in the MLR
supernate is an identified lymphokine. MIF, which activates macrophages and
prevents their migration, has two molecular weights (65 and 25 kD), which are similar
to those we have reported in the present studies [23]. In addition, human MIF focuses
at pls of 4-6 [23]. For guinea pig MIF, the pls are 3.5 and 5.5, with respective
molecular weights of 65 and 25 [24]. Human MIF is resistant to neuraminidase
treatment, and this is consistent with our findings that most of the IL-1-inducing
activity does not bind to Con A sepharose. The fact that some ofthe activity was eluted
with ethylene glycol suggests that there is a mixture of glycosylated proteins in the
MLR which can stimulate IL-I production.
Cerebrospinal fluid (CSF) derived from a murine L-cell line has been studied for its
ability to induce IL-1 [25]. CSF-induced IL-I production was clearly distinguishable
from that of endotoxins since antibody to the L-cell CSF blocks CSF- but not
endotoxin-induced IL-1 production. Chemical characteristics of the L-cell CSF are
different from human CSF. Nevertheless, L-cell CSF seems to be one likely candidate
for an IL-1-inducing lymphokine. Although the L-cell CSF was low in endotoxin
concentration, it remains to be shown that CSF is functioning as a direct or
augmenting IL-1 inducer.
With the molecular cloning of CSF, it seems likely that this issue will be resolved
soon. The studies presented in this report establish the molecular heterogeneity of
lymphocyte products in MLR supernates which induce IL-I production in the absence
of endotoxins. Future studies will focus on the identification of known lymphokines
with this property, or perhaps there is a unique lymphokine responsible for initiating
IL-1 production. The overall clinical importance of identifying such lymphocyte
products will be related to immunologically mediated diseases such as drug fever,
transplantation rejection, hypersensitivity reactions, and autoimmune phenomena.
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